Adenovirus vectors for gene therapy

Details Adenovirus vectors for gene therapy Adenovirus vectors for gene therapy

2008-01-15

2008-01-15

Priebe, Scott D. (Department: 1633)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Genetically modified micro-organism, cell, or virus

C435S320100, C435S455000, C435S456000

Reexamination Certificate

active

07318919

ABSTRACT:
Gene Therapy vectors, which are especially useful for cystic fibrosis, and methods for using the vectors are disclosed.

REFERENCES:
patent: 4920209 (1990-04-01), Davis et al.
patent: 5240846 (1993-08-01), Collins et al.
patent: 5670488 (1997-09-01), Gregory et al.
patent: 5707618 (1998-01-01), Armentano et al.
patent: 5824544 (1998-10-01), Armentano et al.
patent: 5882877 (1999-03-01), Gregory et al.
patent: 5932210 (1999-08-01), Gregory et al.
patent: 6020191 (2000-02-01), Scaria et al.
patent: 6093567 (2000-07-01), Gregory et al.
patent: 6136594 (2000-10-01), Dalemans et al.
patent: 6210939 (2001-04-01), Gregory et al.
patent: 6902907 (2005-06-01), Tsui et al.
patent: 2003/0091534 (2003-05-01), Gregory et al.
patent: 2004/0038404 (2004-02-01), Gregory et al.
patent: 0185573 (1986-06-01), None
patent: 0446017 (1990-09-01), None
patent: WO 91/02796 (1990-08-01), None
patent: WO 91/10734 (1992-12-01), None
patent: WO 93/12240 (1992-12-01), None
patent: WO 93/12756 (1992-12-01), None
patent: WO 95/29993 (1995-11-01), None
patent: WO 96/13597 (1996-05-01), None
patent: WO 96/40955 (1996-12-01), None
Orkin et al., Report and Recommendations of the Panel to Assess the NIH Investment in Research on Gene Therapy, issued by the U.S. National Institutes of Health, Dec. 7, 1995.
Driskell et al., “Current status of gene therapy for inherited lung diseases,” Annu. Rev. Physiol. 65; 585-612, 2003.
Berkner, K.L., “Development of Adenovirus Vectores for the Expression of Heterologous Genes”, Biotechniques 6:616-629, 1988.
Kochanek et al., A new adenovirul vector. replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and alpha-galactosidase, PNAS, 93:5731-5736, 1996.
Wang, Q and Finer, MH., “Second-generation adenovirus vectors”, Nat Med. 2(6):714-716, 1996.
Sassone-Corsi, P. et al., “Far upstream sequences are required for efficient transcription from the adenovirus-2 E1A transcription unit”, Nucleic Acids Research, 11:8735-8745, 1983.
Engelhardt, J.F. et al., “Direct Gene Transfer of Human CFTR into Human Cronchial Epithella of Xenografts with E1-deleted Adenovirus”, Nature Genetics 4:27-34, 1993.
Flotte, T.R. et al., “Expression of the Cystic Fibrosis Transmembrane Conductance Regulator from a Novel Adneno-associated Virus Promoters”, Journal of Biological Chemistry, 268(5):3761-3790, 1993.
Hyde, S.C. et al., “Correction of the Ion Transport Defect in Cystic Fibrosis Transgenic Mice by Gene Therapy”, Nature, 362:250-255, 1993.
Welsh, M.J. and Smith, A.E., “Molecular Mechanisms of CFTR Chloride Channel by Dysfunction in Cystic Fibrosis”, Cell 73:1251-1254, 1993.
Yoshimura, K. et al., “Adenovirus-mediated Augmentation of Cell Transfection with Unmodified Plasmid Vectors”, Journal of Biological Chemistry, 268(4):2300-2303, 1993.
Zabner, J. et al., “Adenovirus-Mediated Gene Transfer Translently Corrects the Chloride Tansport Defect in Nasal Epithelia of Patients with Cystic Fibrosis”, Cell 75:207-216, 1993.
Berkner et al., “Exp. Heterol. Seq. in Adenovirus Vectors”, Current Topics Immin. Microbiology, 158:39-66, 1992.
Abstract, Couture et al., “The Use of Alternative Vectors for Gene Therapy to Lung Epithela and Tissue Culture Cells”, Pediatric Pulmonology, Supplement 8, Sep. 1992.
Grable et al., cis and trans Requirements for the Selective Packaging of Adenovirus Type 5 DNA, Journal of Virology, 66(2):723-731, 1992.
Johnson, L.G. et al., “Efficiency of Gene Transfer for Restoration of Normal Airway Epithelial Function in Cystic Fibrosis”, Nature Genetics, 2:21-25, 1992.
Rosenfeld, M.A. et al., “In Vivo Transfer of the Human Cystic Fibrosis Transmembrane Conductance Regulator Gene to the Airway Epithelium”, Cell 68:143-455, 1992.
Smith, A.E., “Emerging Therapies for Cystic Fibrosis”, Section V-Topics in Biology, Annual Rep. Med. Chem 27:235-243 1992.
Yoshimura, K. et al., “Expression of the Human Cystic Fibrosis Transmembrane Conductance Regulator Gene in the Mouse Lung after In Vivo Intratracheal Plasmid-Mediated Gene Transfer”, Nul. Acids Res. 20:3233-3240, 1992.
Anderson, M.P. et al., “Generation of cAMP-Activated Chloride Currents by Expression of CFTR”, Science 251:202-205, 1991.
Anderson, M.P. et al., “Demonstration the CFTR is a Chloride Channel by Alteration of its Anion Selectivity”, Science 253:202-208, 1991.
Berger, H.A. et al., “Identification and Regulation of the Cystic Fibrosis Transmembrane Conductance Regulator-Generated Chloride Channel”, Journal of Clinical Investigations 88:1422-1431, 1991.
Ferry et al., “Retroviral-Mediated Gene Transfer into Hepatocytes In vivo”, Proceedings of National Academy of Science 88:8377-8361, 1991.
Ghattas et al., “The encephalomyocarditis virus internal ribosome entry site allows efficient coexpression of two genes from a recombinant provirus in cultured cells and in embryos”, Molecular Cell Biology 11(12):5848-5859, 1991.
Kartner, N. et al., “Expression of the Cystic Fibrosis Gene in Non-Epithelial Invertebrate Cells Produces a Regulated Anion Conductance”, Cell 64:681-691, 1991.
Rich, D.P. et al., “Effect of Deleting the R Domain on CFTR-Generated Chloride Channels”, Science 253:205-207, 1991.
Rosenfeld, M.A. et al., “Adenovirus-Mediated Transfer of a Recombinant alpha-1-Antitrypsin Gene to the Lung Epithelium In Vivo”, Science 252:431-434, 1991.
Rosenfeld, M.A. et al., “In Vivo Transfer of the Human Cystic Fibrosis Gene to the Respiratory Epithelium”, Clin. Res. 39(2):311A, 1991.
Tabcharani, J.A. et al., “Phosphorylation-Regulated C1-Channel in CHO Cells Stably Expression the Cystic Fibrosis Gene”, Nature 352:628-631, 1991.
Drumm, M.L. et al., “Correction of the Cystic Fibrosis Defect in Vitro By Retrovirus-Mediated Gene Transfer”, Cell, 1227-1233, 1990.
Gregory, R.J. et al., “Expression and Characterization of the Cystic Fibrosis Transmembrane Conductance Regulator”, Nature, 377:382-388, 1990.
Huang, M.T.F. et al., “Intervening Sequences Increase Efficiency of RNA 3'Processing and Accumulation of Cytoplasmic RNA”, Nucleic Acids Res. 18(4):937-947, 1990.
Rich, D.P. et al., “Expression of the Cystic Fibrosis Transmembrane Conductance Regulator Corrects Defective Chloride Channel Regualtion in Cystic Fibrosis Airway Epithlial Cells”, Nature, 347:358-363, 1990.
Ketner et al., “Complementation of adenovirus E4 mutants by transient expression of E4 cDNA and deletion plasmids”, Nucleic Acids Research 17:3037-3047, 1989.
Davidson et al., “Overproduction of Polyomavirus Middle T Antigen in Mammalian Cells through the Use of an Adenovirus Vector”, Journal of Virology, 61(4):1226-1229, 1987.
Klessig, DF et al., “Introduction, stable integration, and controlled expression of a chimeric adenovirus gene whose product is toxic to the recipient human cell”, Mol Cell Biology, 4(7):1354-1362, 1984.
Bridge et al., “Adenovirus Early Region 4 and Viral DNA Synthesis”, Virology, 193:794-801, 1993.

Affiliated with

Also associated with

Rating

Adenovirus vectors for gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Adenovirus vectors for gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenovirus vectors for gene therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2805145